Shield Therapeutics Market Cap

Shield Therapeutics has a market cap or net worth of 87.61 million as of March 26, 2026. Its market cap has increased by 267.30% in one year.

Market Cap

87.61M

Enterprise Value

99.46M

Revenue

30.29M

Ranking

n/a

PE Ratio

n/a

Stock Price

8.13

Market Cap Chart

Since February 26, 2016, Shield Therapeutics's market cap has decreased from 169.77M to 87.61M, a decrease of -48.40%. That is a compound annual growth rate of -6.35%.

Market Cap History

Date	Market Cap	% Change
Mar 25, 2026	87.61M	-16.23%
Dec 31, 2025	104.59M	395.31%
Dec 31, 2024	21.12M	-59.70%
Dec 29, 2023	52.40M	186.53%
Dec 30, 2022	18.29M	-80.96%
Dec 31, 2021	96.06M	28.62%
Dec 31, 2020	Upgrade Pro	Upgrade Pro
Dec 31, 2019	Upgrade Pro	Upgrade Pro
Dec 31, 2018	Upgrade Pro	Upgrade Pro
Dec 29, 2017	Upgrade Pro	Upgrade Pro
Dec 30, 2016	Upgrade Pro	Upgrade Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Haleon	33.46B
Hikma Pharmaceuticals	2.68B
HUTCHMED (China)	1.76B
Allergy Therapeutics	664.92M
Animalcare Group	176.07M
Venture Life Group	83.18M
ECO Animal Health Group	68.78M
Provexis	25.80M

Market Cap Rankings